Delta 9-tetrahydrocannabinol: a novel treatment for experimental autoimmune encephalomyelitis (1989)

Posted on by WOCredentials

“as THC has been shown to inhibit both clinical and histologic [experimental autoimmune encephalomyelitis], it may prove to be a new and relatively innocuous agent for the treatment of immune-mediated diseases.”

Lyman, W. D., Sonett, J. R., Brosnan, C. F., Elkin, R., & Bornstein, M. B. (1989). Δ9-Tetrahydrocannabinol: a novel treatment for experimental autoimmune encephalomyelitis. Journal of Neuroimmunology, 23(1), 73-81. DOI: 10.1016/0165-5728(89)90075-1

Read more…

Related Posts

A chronic low dose of THC restores cognitive function in old mice (2017)

“Here we show that a low dose of Δ9-tetrahydrocannabinol (THC) reversed the age-related decline in cognitive performance of mice aged 12 and 18 months. This behavioral effect was accompanied by […]

Cannabis link to relieving intestinal inflammation explained

“new research from the University of Massachusetts Medical School and the University of Bath showing that endocannabinoids help control and prevent intestinal inflammation in mice”

Interaction between cytokines, cannabinoids and the nervous system (2010)

“The [endocannabinoid system (ES)] participates in the regulation of immune responses in the nervous system. Activation of the cannabinoid system is associated with therapeutic effects that may be mediated by […]